MXPA04005310A - Inhibidores de fosfolipasa a2 citosolica. - Google Patents
Inhibidores de fosfolipasa a2 citosolica.Info
- Publication number
- MXPA04005310A MXPA04005310A MXPA04005310A MXPA04005310A MXPA04005310A MX PA04005310 A MXPA04005310 A MX PA04005310A MX PA04005310 A MXPA04005310 A MX PA04005310A MX PA04005310 A MXPA04005310 A MX PA04005310A MX PA04005310 A MXPA04005310 A MX PA04005310A
- Authority
- MX
- Mexico
- Prior art keywords
- inhibitors
- phospholipase
- cytosolic phospholipase
- enzymes
- compounds
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 102100037611 Lysophospholipase Human genes 0.000 title 1
- 108020002496 Lysophospholipase Proteins 0.000 title 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 102000015439 Phospholipases Human genes 0.000 abstract 1
- 108010064785 Phospholipases Proteins 0.000 abstract 1
- 108010058864 Phospholipases A2 Proteins 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000002475 indoles Chemical class 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 150000003839 salts Chemical group 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Esta invencion proporciona los compuestos de indol sustituido de la formula general (1)(ver formula I)y las formas de sal farmaceuticamente aceptables de los mismos, y metodos para usar los compuestos como inhibidores de la actividad de varias enzimas de fosfolipasa, especialmente de las enzimas de fosoflipasa A2, en tratamiento medico, prevencion e inhibicion del dolor e inflamacion.
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33459101P | 2001-12-03 | 2001-12-03 | |
| US33458801P | 2001-12-03 | 2001-12-03 | |
| US33460501P | 2001-12-03 | 2001-12-03 | |
| US4196402P | 2002-10-18 | 2002-10-18 | |
| PCT/US2002/038311 WO2003048122A2 (en) | 2001-12-03 | 2002-12-02 | Inhibitors of cytosolic phospholipase a2 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA04005310A true MXPA04005310A (es) | 2004-09-13 |
Family
ID=35788835
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA04005310A MXPA04005310A (es) | 2001-12-03 | 2002-12-02 | Inhibidores de fosfolipasa a2 citosolica. |
Country Status (1)
| Country | Link |
|---|---|
| MX (1) | MXPA04005310A (es) |
-
2002
- 2002-12-02 MX MXPA04005310A patent/MXPA04005310A/es active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2005KO00312A (es) | ||
| MXPA04002397A (es) | Inhibidores de histona deacetilasa. | |
| BG104780A (en) | Inhibitors of phospholipase enzymes | |
| MY141661A (en) | 17b-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | |
| TW200613306A (en) | Imidazotriazines as protein kinase inhibitors | |
| YU84603A (sh) | Novi inhibitori tirozin kinaze | |
| WO2001044247A3 (en) | Agents and methods for the treatment of proliferative diseases | |
| SG132683A1 (en) | Imidazopyrazine tyrosine kinase inhibitors | |
| EA200401043A1 (ru) | Лечение доброкачественной гиперплазии простаты селективным модулятором рецептора андрогенов ( sarm ) | |
| MY151032A (en) | Treatment of tnf? related disorders | |
| TR200201505T2 (tr) | Terapötik maddeler olarak pirazolopirimidinler | |
| GB0223040D0 (en) | Therapeutic compounds | |
| AU2001248701A1 (en) | Inhibitors of histone deacetylase | |
| MXPA05003104A (es) | Hidromorfonas n-sustituidas y uso de las mismas. | |
| SI1546127T1 (sl) | Novi pirimidinamidni derivati in njihova uporaba | |
| DE60312736D1 (de) | 1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems | |
| AP2003002929A0 (en) | Pyrrolopyrimidines as protein kinase inhibitors | |
| MY124786A (en) | Bis-arylsulfones | |
| MY141528A (en) | Anilinopyrazole derivatives useful for the treatment of diabetes | |
| SG162614A1 (en) | Bicyclic 6-alkylidene-penems as beta-lactamases inhibitors | |
| MXPA04005809A (es) | Inhibidores de proteinas quinasas. | |
| AU2003258630A1 (en) | Pyrimidine derivatives as selective cox-2 inhibitors | |
| TW200503666A (en) | Treatment of type 1 diabetes with pde5 inhibitors | |
| AU2576901A (en) | Agents and methods for the treatment of proliferative diseases | |
| MXPA04005310A (es) | Inhibidores de fosfolipasa a2 citosolica. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |